Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2020

View Archived Issues

GNOS-PV02 vaccine to be evaluated in patients with HCC

AI-generated compound begins phase I study in Japan for obsessive-compulsive disorder

Inovio and Beijing Advaccine collaborate to advance new vaccine against new coronavirus in China

BREEZE-AD5 phase II study of baricitinib in AD meets primary endpoint

German Medicines Agency approves phase II study of FOL-005

Kedrion Biopharma completes enrollment in phase III CARES10 study

Cerevel starts dosing volunteers in phase I study of CVL-936

First patient dosed in phase Ib study of GMI-1359 in breast cancer

FDA accepts IND application for FS-120 bispecific antibody

BBI-608 plus pembrolizumab shows encouraging antitumor activity in mCRC

Magrolimab plus cetuximab as a promising immunotherapeutic treatment regimen in CRC

Phase II study of PBI-05204 in mPDA does not meet primary endpoint

Fimbrion Therapeutics and GlaxoSmithKline describe Escherichia coli FimH inhibitors

New high affinity nerve growth factor receptor inhibitors identified at Medshine Discovery

Naltrexone prodrugs synthesized at Alkermes

Novartis patents compounds for IKZF2-dependent disease

Recordati Industria Chimica e Farmaceutica discovers P2X3 and P2X2/3 antagonists

"Confused and disorganized": Stress, identity crises part of growing up -- for organoids

RC-48-ADC shows meaningful benefit in phase I solid tumors trial

CEACAM6 levels linked to sensitivity to pelareorep in pancreatic adenocarcinoma

IRICoR, UdeM and Medigene establish collaboration on novel cancer antigens

Phase I study of Rani's orally delivered octreotide meets primary and secondary endpoints

Fuzionaire Diagnostics establishes new research collaboration in neurodegeneration

IND clearance for VistaGen's AV-101 for levodopa-induced dyskinesia in Parkinson's

Immune Response BioPharma plans IND filing for new SARS/coronavirus vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...